Northern Trust’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $113K | Hold |
22,673
| – | – | ﹤0.01% | 4085 |
|
2025
Q1 | $182K | Hold |
22,673
| – | – | ﹤0.01% | 3973 |
|
2024
Q4 | $168K | Buy |
+22,673
| New | +$168K | ﹤0.01% | 4036 |
|
2023
Q4 | – | Sell |
-45
| Closed | -$1.31K | – | 4478 |
|
2023
Q3 | $1.31K | Hold |
45
| – | – | ﹤0.01% | 4458 |
|
2023
Q2 | $3.85K | Hold |
45
| – | – | ﹤0.01% | 4518 |
|
2023
Q1 | $19K | Hold |
45
| – | – | ﹤0.01% | 4458 |
|
2022
Q4 | $54.7K | Hold |
45
| – | – | ﹤0.01% | 4263 |
|
2022
Q3 | $36K | Buy |
45
+5
| +13% | +$4K | ﹤0.01% | 4411 |
|
2022
Q2 | $58K | Sell |
40
-146
| -78% | -$212K | ﹤0.01% | 4365 |
|
2022
Q1 | $388K | Buy |
186
+1
| +0.5% | +$2.09K | ﹤0.01% | 3840 |
|
2021
Q4 | $907K | Buy |
185
+5
| +3% | +$24.5K | ﹤0.01% | 3580 |
|
2021
Q3 | $1.13M | Sell |
180
-33
| -15% | -$207K | ﹤0.01% | 3512 |
|
2021
Q2 | $2.01M | Buy |
213
+26
| +14% | +$245K | ﹤0.01% | 3352 |
|
2021
Q1 | $1.62M | Buy |
187
+12
| +7% | +$104K | ﹤0.01% | 3360 |
|
2020
Q4 | $1.33M | Buy |
175
+11
| +7% | +$83.7K | ﹤0.01% | 3394 |
|
2020
Q3 | $1.07M | Buy |
164
+41
| +33% | +$268K | ﹤0.01% | 3368 |
|
2020
Q2 | $920K | Buy |
123
+25
| +26% | +$187K | ﹤0.01% | 3386 |
|
2020
Q1 | $703K | Buy |
98
+19
| +24% | +$136K | ﹤0.01% | 3352 |
|
2019
Q4 | $1.22M | Sell |
79
-2
| -2% | -$31K | ﹤0.01% | 3327 |
|
2019
Q3 | $769K | Buy |
81
+62
| +326% | +$589K | ﹤0.01% | 3459 |
|
2019
Q2 | $304K | Buy |
19
+6
| +46% | +$96K | ﹤0.01% | 3694 |
|
2019
Q1 | $222K | Buy |
13
+6
| +86% | +$102K | ﹤0.01% | 3752 |
|
2018
Q4 | $65K | Buy |
7
+2
| +40% | +$18.6K | ﹤0.01% | 4000 |
|
2018
Q3 | $63K | Hold |
5
| – | – | ﹤0.01% | 4105 |
|
2018
Q2 | $59K | Sell |
5
-6
| -55% | -$70.8K | ﹤0.01% | 4100 |
|
2018
Q1 | $135K | Buy |
11
+7
| +175% | +$85.9K | ﹤0.01% | 3902 |
|
2017
Q4 | $36K | Buy |
+4
| New | +$36K | ﹤0.01% | 4102 |
|